| Literature DB >> 35525247 |
Nathan E Reticker-Flynn1, Weiruo Zhang2, Julia A Belk3, Pamela A Basto4, Nichole K Escalante3, Genay O W Pilarowski3, Alborz Bejnood2, Maria M Martins3, Justin A Kenkel3, Ian L Linde3, Sreya Bagchi3, Robert Yuan3, Serena Chang5, Matthew H Spitzer6, Yaron Carmi7, Jiahan Cheng3, Lorna L Tolentino3, Okmi Choi3, Nancy Wu3, Christina S Kong8, Andrew J Gentles9, John B Sunwoo10, Ansuman T Satpathy11, Sylvia K Plevritis12, Edgar G Engleman13.
Abstract
For many solid malignancies, lymph node (LN) involvement represents a harbinger of distant metastatic disease and, therefore, an important prognostic factor. Beyond its utility as a biomarker, whether and how LN metastasis plays an active role in shaping distant metastasis remains an open question. Here, we develop a syngeneic melanoma mouse model of LN metastasis to investigate how tumors spread to LNs and whether LN colonization influences metastasis to distant tissues. We show that an epigenetically instilled tumor-intrinsic interferon response program confers enhanced LN metastatic potential by enabling the evasion of NK cells and promoting LN colonization. LN metastases resist T cell-mediated cytotoxicity, induce antigen-specific regulatory T cells, and generate tumor-specific immune tolerance that subsequently facilitates distant tumor colonization. These effects extend to human cancers and other murine cancer models, implicating a conserved systemic mechanism by which malignancies spread to distant organs.Entities:
Keywords: ISGs; MHC-I; NK cells; PD-L1; Tregs; interferon; lymph nodes; metastasis; regulatory T cells; tolerance
Mesh:
Year: 2022 PMID: 35525247 PMCID: PMC9149144 DOI: 10.1016/j.cell.2022.04.019
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 66.850